Project:

SEMPER

Secondary Malignoma - Prospective Evaluation of the Radiotherapeutic Dose Distribution as the Cause for Induction

   
Funding: Oncotyrol
   
Duration: 2013 - 2015
   
Partner
  • Med. Universität Innsbruck, Univ.-Klinik für Strahlentherapie (Peter Lukas, Paul Eichberger)
  • UMIT, Institut für Bildanalyse (Rainer Schubert, Patrik Raudaschl)
  • UMIT, Institut für Medizinische Informatik (Elske Ammenwerth, Werner Hackl)
  • UMIT, Institut für Bioinformatik (Matthias Dehmer)
  • UMIT, Forschungsgruppe eHealth und Telemedizin (Alexander Hörbst, Stefan Oberbichler)
  • Firma Elekta (Rolf Baumann, Markus Wenke)
   
Project members at IIG

This email address is being protected from spambots. You need JavaScript enabled to view it., Werner Hackl, Alexander Hörbst, Stefan Oberbichler

   
Background:

Based on the development of novel linear accelerator models, new radiation treatment techniques such as IMRT, IGRT and VMAT become applicable. However, radioation with minimal dose can be the reason for the induction of secondary malignancy many years afterwards.

   
Objectives:

The objective of this project is to develop the platform and framework to perform a long term (range 20 years or more) study based on the preconditions given by this new radiotherapy technology.

   
Methods:

Systems analysis and requirements analysis regarding clinical research questions, data needs, interfaces, data integration, data modell, data input and data output

 

   
Results:

The project is running at the moment.

Links:

 

   
Publications:

(please find a complete list of publications in our list of publications)